KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Current Assets (2020 - 2026)

AbCellera Biologics filings provide 7 years of Current Assets readings, the most recent being $664.6 million for Q1 2026.

  • Quarterly Current Assets fell 13.12% to $664.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $664.6 million through Mar 2026, down 13.12% year-over-year, with the annual reading at $728.2 million for FY2025, 3.08% down from the prior year.
  • Current Assets hit $664.6 million in Q1 2026 for AbCellera Biologics, down from $728.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.2 billion in Q1 2022 and bottomed at $664.6 million in Q1 2026.
  • Average Current Assets over 5 years is $866.3 million, with a median of $813.9 million recorded in 2024.
  • The largest annual shift saw Current Assets skyrocketed 32.4% in 2022 before it fell 19.9% in 2023.
  • AbCellera Biologics' Current Assets stood at $1.0 billion in 2022, then decreased by 14.97% to $872.0 million in 2023, then dropped by 13.83% to $751.4 million in 2024, then decreased by 3.08% to $728.2 million in 2025, then fell by 8.74% to $664.6 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Current Assets are $664.6 million (Q1 2026), $728.2 million (Q4 2025), and $695.1 million (Q3 2025).